What is the recommended management for a monochorionic diamniotic pregnancy complicated by twin-to-twin transfusion syndrome?

Management of Twin-to-Twin Transfusion Syndrome

Fetoscopic laser surgery is the standard treatment for stage II through stage IV twin-to-twin transfusion syndrome presenting between 16 and 26 weeks of gestation, and all patients qualifying for laser therapy must be referred to a fetal intervention center. 1

Surveillance Protocol

All monochorionic-diamniotic twin pregnancies require:

• Start ultrasound surveillance at 16 weeks of gestation 1
• Continue every 2 weeks until delivery (more frequently if clinical concerns arise) 1
• Each ultrasound must assess:
  • Amniotic fluid volumes on both sides of the intertwin membrane
  • Presence or absence of urine-filled fetal bladders
  • Doppler study of umbilical arteries (ideally) 1

Treatment Algorithm by Stage

Stage I TTTS (16-26 weeks)

• Expectant management with weekly fetal surveillance for asymptomatic patients 1
• Consider fetoscopic laser surgery if:
  • Maternal symptoms from polyhydramnios develop
  • Additional concerning factors present 1

Stage II-IV TTTS (16-26 weeks)

• Fetoscopic laser surgery is mandatory (GRADE 1A recommendation) 1
• This represents the highest level of evidence-based recommendation
• Laser surgery significantly improves survival compared to amnioreduction, with contemporary data showing dual survival in up to 65% of cases and at least one survivor in up to 88% 2

Early (<16 weeks) or Late (>26 weeks) Presentation

• Individualized approach to laser surgery 1
• Late TTTS (after 26 weeks) treated with fetoscopic laser shows significantly higher gestational age at birth (32+3 vs 29+1 weeks) and better perinatal survival (89.1% vs 71.8% for at least one twin) compared to traditional management with amniodrainage or emergency cesarean delivery 3

Post-Laser Management

After fetoscopic laser therapy:

• Weekly surveillance for 6 weeks 1
• Then resume every-other-week surveillance 1
• Increase frequency if concerns for:
  • Post-laser TTTS recurrence
  • Post-laser twin anemia-polycythemia sequence (TAPS)
  • Fetal growth restriction 1

Delivery Timing

Following successful laser surgery with dual survivors:

• Deliver at 34-36 weeks of gestation (without other indications for earlier delivery) 1

If single fetal demise occurs post-treatment:

• Deliver at 39 weeks (full-term) to avoid prematurity complications in the surviving co-twin 1

Mode of delivery:

• Fetoscopic laser surgery does not influence mode of delivery 1, 4

Critical Pitfalls to Avoid

1. Do not delay referral: All patients with stage II-IV TTTS between 16-26 weeks must be referred immediately to a fetal intervention center 1. This is designated as "Best Practice" by SMFM.

2. Do not use amnioreduction as primary treatment for stage II-IV: Evidence clearly demonstrates fetoscopic laser ablation is superior to serial amnioreductions for survival and neurological outcomes 5, 2

3. Do not miss chorionicity determination: First-trimester sonographic determination of chorionicity and amnionicity is essential 1 - this sets the entire monitoring strategy

4. Do not stop surveillance after laser: Post-laser complications including recurrent TTTS and TAPS occur, requiring continued vigilant monitoring 1

Long-Term Considerations

Despite improved survival with laser therapy, survivors remain at risk for:

• Neurodevelopmental impairment (3-14% of survivors) 6
• Cardiovascular complications (8% develop pulmonary stenosis or aortic coarctation) 6
• Renal dysfunction, primarily in donor twins 6
• Preterm birth remains a significant contributor to morbidity despite treatment 2

These outcomes underscore the importance of multidisciplinary long-term follow-up for all TTTS survivors to optimize developmental outcomes 6.